InsiderTrades.com logo

SRPT Insider Trading

Insider Ownership Percentage: 7.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,764,423.04

Sarepta Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Sarepta Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sarepta Therapeutics Share Price & Price History

Current Price: $22.82
Price Change: ▲ Price Increase of +0.98 (4.49%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for SRPT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Sarepta Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/12/2025Claude NicaiseDirectorSell2,491$99.64$248,203.2427,812View SEC Filing Icon  
12/12/2024Hans Rudolf WigzellDirectorSell10,500$124.84$1,310,820.0022,840View SEC Filing Icon  
12/5/2024Kathryn Jean BoorDirectorSell1,636$125.55$205,399.805,880View SEC Filing Icon  
8/30/2024Ian Michael EstepanCFOSell5,985$137.36$822,099.6033,946View SEC Filing Icon  
8/16/2024Michael Andrew ChambersDirectorBuy37,038$133.80$4,955,684.40284,034View SEC Filing Icon  
6/25/2024Ryan Edward BrownEVPSell38,957$161.61$6,295,840.7717,129View SEC Filing Icon  
6/24/2024Bilal ArifInsiderSell7,859$163.08$1,281,645.7221,261View SEC Filing Icon  
5/2/2024Dallan MurrayInsiderSell3,635$140.00$508,900.0018,125View SEC Filing Icon  
3/11/2024Kathryn Jean BoorDirectorSell761$122.93$93,549.737,516View SEC Filing Icon  
3/8/2024Hans Rudolf WigzellDirectorSell15,000$123.25$1,848,750.0022,840View SEC Filing Icon  
3/5/2024Stephen MayoDirectorSell3,135$122.96$385,479.606,621View SEC Filing Icon  
3/1/2024Bilal ArifInsiderSell2,000$128.84$257,680.0026,836View SEC Filing Icon  
3/1/2024Ian Michael EstepanCFOSell1,200$128.30$153,960.0039,114View SEC Filing Icon  
11/3/2023Douglas S. IngramCEOBuy25,225$79.36$2,001,856.00390,307View SEC Filing Icon  
11/3/2023Richard BarryDirectorBuy50,000$78.81$3,940,500.00140,000View SEC Filing Icon  
8/14/2023Michael Andrew ChambersDirectorBuy9,979$109.47$1,092,401.13246,996View SEC Filing Icon  
8/10/2023Michael Andrew ChambersDirectorBuy34,867$106.15$3,701,132.05213,331View SEC Filing Icon  
8/4/2023Hans Rudolf WigzellDirectorSell15,000$106.72$1,600,800.0020,994View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Sarepta Therapeutics (NASDAQ:SRPT)

86.68% of Sarepta Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SRPT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Sarepta Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/2/2025Allworth Financial LP1,803$35K0.0%+2,098.8%0.002%Search for SEC Filing on Google Icon
11/17/2025Jacobs Levy Equity Management Inc.262,331$5.06M0.0%+7.3%0.250%Search for SEC Filing on Google Icon
11/17/2025CANADA LIFE ASSURANCE Co97,041$1.83M0.0%+35.7%0.093%Search for SEC Filing on Google Icon
11/17/2025PharVision Advisers LLC18,523$0.36M0.2%N/A0.018%Search for SEC Filing on Google Icon
11/17/2025Virtus Advisers LLC25,800$0.50M0.3%N/A0.025%Search for SEC Filing on Google Icon
11/17/2025Voleon Capital Management LP501,142$9.66M0.2%+4,651.5%0.478%Search for SEC Filing on Google Icon
11/17/2025Voloridge Investment Management LLC1,308,738$25.22M0.1%-11.2%1.249%Search for SEC Filing on Google Icon
11/17/2025Verition Fund Management LLC148,367$2.86M0.0%+65.1%0.142%Search for SEC Filing on Google Icon
11/17/2025Sherbrooke Park Advisers LLC14,914$0.29M0.1%-44.8%0.014%Search for SEC Filing on Google Icon
11/17/2025Quarry LP2,914$56K0.0%N/A0.003%Search for SEC Filing on Google Icon
11/17/2025Mariner LLC54,290$1.05M0.0%N/A0.052%Search for SEC Filing on Google Icon
11/17/2025Mercer Global Advisors Inc. ADV21,725$0.42M0.0%N/A0.021%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC284,210$5.48M0.0%-97.4%0.271%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.43,208$0.83M0.0%+1.8%0.041%Search for SEC Filing on Google Icon
11/17/2025Boxer Capital Management LLC250,000$4.82M1.5%+900.0%0.239%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP37,411$0.72M0.0%N/A0.036%Search for SEC Filing on Google Icon
11/17/2025Braidwell LP832,100$16.04M0.5%N/A0.794%Search for SEC Filing on Google Icon
11/17/2025Aquatic Capital Management LLC188,453$3.63M0.1%-12.7%0.180%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC351,984$6.78M0.1%+134.8%0.336%Search for SEC Filing on Google Icon
11/17/2025Alliancebernstein L.P.88,343$1.70M0.0%-40.5%0.084%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.217,287$4.19M0.0%-52.9%0.207%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC23,724$0.46M0.0%-73.9%0.023%Search for SEC Filing on Google Icon
11/14/2025Creative Planning37,078$0.71M0.0%N/A0.035%Search for SEC Filing on Google Icon
11/14/2025Ancora Advisors LLC1,500$29K0.0%+200.0%0.001%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.11,897$0.23M0.0%-29.1%0.011%Search for SEC Filing on Google Icon
11/14/2025Amundi969,826$18.69M0.0%+378.2%0.926%Search for SEC Filing on Google Icon
11/14/2025Caisse de depot et placement du Quebec66,000$1.27M0.0%N/A0.063%Search for SEC Filing on Google Icon
11/14/2025Freestone Grove Partners LP18,515$0.36M0.0%N/A0.018%Search for SEC Filing on Google Icon
11/14/2025ADAR1 Capital Management LLC349,807$6.74M0.6%+31.8%0.334%Search for SEC Filing on Google Icon
11/14/2025Zurcher Kantonalbank Zurich Cantonalbank 27,500$0.53M0.0%+6.0%0.026%Search for SEC Filing on Google Icon
11/14/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC233,461$4.50M0.0%-41.1%0.223%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP2,137,764$41.20M0.1%-89.1%2.040%Search for SEC Filing on Google Icon
11/14/2025Vident Advisory LLC20,856$0.40M0.0%N/A0.020%Search for SEC Filing on Google Icon
11/14/2025Union Square Park Capital Management LLC105,000$2.02M0.7%N/A0.107%Search for SEC Filing on Google Icon
11/14/2025iSAM Funds UK Ltd1,307$25K0.0%N/A0.001%Search for SEC Filing on Google Icon
11/14/2025Comerica Bank24,757$0.48M0.0%-10.2%0.025%Search for SEC Filing on Google Icon
11/14/2025Quinn Opportunity Partners LLC376,244$7.25M0.5%+29.9%0.385%Search for SEC Filing on Google Icon
11/13/2025Jump Financial LLC301,009$5.80M0.1%-93.5%0.308%Search for SEC Filing on Google Icon
11/13/2025Entropy Technologies LP46,130$0.89M0.1%N/A0.047%Search for SEC Filing on Google Icon
11/13/2025Invesco Ltd.832,638$16.05M0.0%+242.0%0.852%Search for SEC Filing on Google Icon
11/13/2025Sei Investments Co.10,290$0.20M0.0%-41.0%0.011%Search for SEC Filing on Google Icon
11/13/2025Connor Clark & Lunn Investment Management Ltd.1,745,051$33.63M0.1%+183.5%1.786%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets1,781,348$34.33M0.0%-80.3%1.823%Search for SEC Filing on Google Icon
11/13/2025Mackenzie Financial Corp49,548$0.96M0.0%+71.3%0.051%Search for SEC Filing on Google Icon
11/13/2025Van ECK Associates Corp9,937$0.19M0.0%-88.2%0.010%Search for SEC Filing on Google Icon
11/13/2025Legal & General Group Plc266,562$5.14M0.0%+13.5%0.273%Search for SEC Filing on Google Icon
11/13/2025Swiss National Bank171,483$3.30M0.0%+3.0%0.175%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.168,294$3.24M0.0%-91.2%0.172%Search for SEC Filing on Google Icon
11/13/2025Parallel Advisors LLC2,016$39K0.0%+165.3%0.002%Search for SEC Filing on Google Icon
11/13/2025Blair William & Co. IL33,632$0.65M0.0%+23.8%0.034%Search for SEC Filing on Google Icon
11/13/2025First Trust Advisors LP1,939,781$37.38M0.0%+209.1%1.985%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP651,598$12.56M0.0%-18.9%0.667%Search for SEC Filing on Google Icon
11/12/2025Victory Capital Management Inc.13,782$0.27M0.0%-20.5%0.014%Search for SEC Filing on Google Icon
11/12/2025Focus Partners Advisor Solutions LLC18,173$0.32M0.0%N/A0.019%Search for SEC Filing on Google Icon
11/12/2025New Age Alpha Advisors LLC39,472$0.76M0.0%-2.3%0.040%Search for SEC Filing on Google Icon
11/12/2025Rafferty Asset Management LLC175,135$3.38M0.0%+16.9%0.179%Search for SEC Filing on Google Icon
11/12/2025Quantbot Technologies LP8,914$0.17M0.0%+112.9%0.009%Search for SEC Filing on Google Icon
11/12/2025Erste Asset Management GmbH2,685,945$50.59M0.5%+65.7%2.749%Search for SEC Filing on Google Icon
11/12/2025Xponance Inc.11,945$0.23M0.0%-33.2%0.012%Search for SEC Filing on Google Icon
11/10/2025AXQ Capital LP14,619$0.28M0.1%-72.8%0.015%Search for SEC Filing on Google Icon
11/10/2025Sound View Wealth Advisors Group LLC12,695$0.25M0.0%+6.1%0.013%Search for SEC Filing on Google Icon
11/10/2025Clearstead Advisors LLC12,369$0.24M0.0%+27.5%0.013%Search for SEC Filing on Google Icon
11/10/2025China Universal Asset Management Co. Ltd.17,128$0.33M0.0%-13.2%0.018%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP20,565$0.40M0.0%-67.2%0.021%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.10,817,446$208.45M0.0%+18.1%11.071%Search for SEC Filing on Google Icon
11/7/2025PNC Financial Services Group Inc.7,078$0.14M0.0%+87.3%0.007%Search for SEC Filing on Google Icon
11/7/2025Shell Asset Management Co.1,350$26K0.0%-54.0%0.001%Search for SEC Filing on Google Icon
11/7/2025Aberdeen Group plc1,982,764$38.21M0.1%+59.6%2.029%Search for SEC Filing on Google Icon
11/6/2025Public Sector Pension Investment Board381,172$7.35M0.0%N/A0.390%Search for SEC Filing on Google Icon
11/6/2025ING Groep NV240,800$4.64M0.0%-50.8%0.246%Search for SEC Filing on Google Icon
11/6/2025Rhumbline Advisers178,421$3.44M0.0%-33.3%0.183%Search for SEC Filing on Google Icon
11/6/2025Prospera Financial Services Inc14,567$0.28M0.0%N/A0.015%Search for SEC Filing on Google Icon
11/6/2025Profund Advisors LLC38,874$0.75M0.0%+22.3%0.040%Search for SEC Filing on Google Icon
11/5/2025Savant Capital LLC22,760$0.44M0.0%N/A0.023%Search for SEC Filing on Google Icon
11/4/2025Atlantic Union Bankshares Corp2,500$48K0.0%N/A0.003%Search for SEC Filing on Google Icon
11/4/2025Principal Financial Group Inc.468,067$9.02M0.0%+109.1%0.479%Search for SEC Filing on Google Icon
11/4/2025Thrivent Financial for Lutherans70,493$1.36M0.0%+204.6%0.072%Search for SEC Filing on Google Icon
11/3/2025AlphaQuest LLC2,561$49K0.0%+118.3%0.003%Search for SEC Filing on Google Icon
11/3/2025Arizona State Retirement System26,165$0.50M0.0%+2.8%0.027%Search for SEC Filing on Google Icon
11/3/2025New York State Common Retirement Fund36,471$0.70M0.0%-71.9%0.037%Search for SEC Filing on Google Icon
11/3/2025Federated Hermes Inc.1,308,691$25.22M0.0%+0.0%1.339%Search for SEC Filing on Google Icon
11/3/2025Stonehage Fleming Financial Services Holdings Ltd9,614$0.19M0.0%N/A0.010%Search for SEC Filing on Google Icon
11/3/2025Hussman Strategic Advisors Inc.84,000$1.62M0.4%+33.3%0.086%Search for SEC Filing on Google Icon
11/3/2025Pilgrim Partners Asia Pte Ltd4,600$89K0.0%N/A0.005%Search for SEC Filing on Google Icon
10/31/2025Mutual of America Capital Management LLC10,945$0.21M0.0%-77.6%0.011%Search for SEC Filing on Google Icon
10/31/2025PFG Investments LLC24,543$0.47M0.0%-3.5%0.025%Search for SEC Filing on Google Icon
10/31/2025Y Intercept Hong Kong Ltd78,735$1.52M0.0%-91.0%0.081%Search for SEC Filing on Google Icon
10/31/2025Mitsubishi UFJ Trust & Banking Corp22,941$0.44M0.0%N/A0.023%Search for SEC Filing on Google Icon
10/30/2025Covestor Ltd2,789$53K0.0%+1,081.8%0.003%Search for SEC Filing on Google Icon
10/30/2025Universal Beteiligungs und Servicegesellschaft mbH45,418$0.88M0.0%N/A0.046%Search for SEC Filing on Google Icon
10/29/2025Dynasty Wealth Management LLC14,333$0.28M0.0%N/A0.015%Search for SEC Filing on Google Icon
10/29/2025Wealth Enhancement Advisory Services LLC43,778$0.84M0.0%N/A0.045%Search for SEC Filing on Google Icon
10/29/2025Amalgamated Bank31,960$0.62M0.0%-31.1%0.033%Search for SEC Filing on Google Icon
10/29/2025Maryland State Retirement & Pension System18,280$0.35M0.0%N/A0.019%Search for SEC Filing on Google Icon
10/27/2025Nordea Investment Management AB71,851$1.31M0.0%+3.6%0.074%Search for SEC Filing on Google Icon
10/24/2025New York State Teachers Retirement System82,415$1.59M0.0%+7.8%0.084%Search for SEC Filing on Google Icon
10/24/2025Bayforest Capital Ltd9,674$0.19M0.1%N/A0.010%Search for SEC Filing on Google Icon
10/24/2025Oregon Public Employees Retirement Fund22,000$0.42M0.0%+9.2%0.023%Search for SEC Filing on Google Icon
10/24/2025State of Alaska Department of Revenue49,113$0.95M0.0%+343.7%0.050%Search for SEC Filing on Google Icon
10/23/2025Nisa Investment Advisors LLC40,309$0.78M0.0%+41,888.5%0.041%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Sarepta Therapeutics logo
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with duchenne with a confirmed mutation in the duchenne gene. The company is also developing SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Genevant Sciences; University of Florida; Dyno Therapeutics; Hansa Biopharma; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Read More on Sarepta Therapeutics

Today's Range

Now: $22.82
Low: $21.47
High: $23.00

50 Day Range

MA: $20.71
Low: $16.20
High: $24.45

52 Week Range

Now: $22.82
Low: $10.41
High: $131.31

Volume

3,388,621 shs

Average Volume

3,897,950 shs

Market Capitalization

$2.39 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.54

Who are the company insiders with the largest holdings of Sarepta Therapeutics?

Sarepta Therapeutics' top insider investors include:
  1. Michael Andrew Chambers (Director)
  2. Ian Michael Estepan (CFO)
  3. Claude Nicaise (Director)
  4. Bilal Arif (Insider)
  5. Hans Lennart Rudolf Wigzell (Director)
  6. Dallan Murray (Insider)
  7. Ryan Edward Brown (EVP)
  8. Kathryn Jean Boor (Director)
  9. Stephen Mayo (Director)
Learn More about top insider investors at Sarepta Therapeutics.

Who are the major institutional investors of Sarepta Therapeutics?

Sarepta Therapeutics' top institutional shareholders include:
  1. Vanguard Group Inc. — 11.07%
  2. Erste Asset Management GmbH — 2.75%
  3. Two Sigma Investments LP — 2.04%
  4. Aberdeen Group plc — 2.03%
  5. First Trust Advisors LP — 1.99%
  6. BNP Paribas Financial Markets — 1.82%
Learn More about top institutional investors of Sarepta Therapeutics stock.

Which institutional investors are selling Sarepta Therapeutics stock?

During the previous quarter, SRPT stock was sold by these institutional investors:
  1. Voya Investment Management LLC
  2. Two Sigma Investments LP
  3. Millennium Management LLC
  4. BNP Paribas Financial Markets
  5. Jump Financial LLC
  6. Russell Investments Group Ltd.
  7. Assenagon Asset Management S.A.
  8. Y Intercept Hong Kong Ltd
During the previous year, company insiders that have sold Sarepta Therapeutics company stock include:
  1. Michael Andrew Chambers (Director)
  2. Ian Michael Estepan (CFO)
  3. Claude Nicaise (Director)
Learn More investors selling Sarepta Therapeutics stock.

Which institutional investors are buying Sarepta Therapeutics stock?

During the previous quarter, SRPT stock was bought by institutional investors including:
  1. Vanguard Group Inc.
  2. First Trust Advisors LP
  3. Connor Clark & Lunn Investment Management Ltd.
  4. Erste Asset Management GmbH
  5. Braidwell LP
  6. Amundi
  7. Aberdeen Group plc
  8. Invesco Ltd.